儿科失眠的药理管理
Sakshi Dhir1, Nicolette Karim1, Haley Berka1
1Grossman School of Medicine, New York University, New York, NY, United States.
概括
儿科失眠是常见的,并影响发展,失眠的认知行为疗法 (CBT-I) 作为一线治疗. 本综述评估了治疗儿科失眠的药物,对其证据,副作用和风险与益处进行分级.
科学领域:
- 儿科睡眠医学 儿科睡眠医学
- 药理学 药理学是指药理学的学科.
- 儿童精神病学 儿童精神病学
背景情况:
- 失眠是儿童和青少年普遍存在的睡眠障碍,影响发育,并经常持续到成年.
- 它的流行因发育障碍,精神病并发症和COVID-19大流行等因素而加剧.
- 医疗保健提供者经常管理儿科失眠,尽管缺乏FDA批准的药物.
研究的目的:
- 审查和评分所有已发表的治疗儿科失眠的药物研究.
- 为治疗儿科患者失眠的临床医生提供基于证据的指导.
- 评估儿科失眠药物治疗的风险和益处概况.
主要方法:
- 一个全面的叙事审查发表的药物研究在儿科失眠.
- 基于证据强度,副作用概况和并发症的确定研究的分类.
- 通过评估整体风险与益处对药理疗法的分级.
主要成果:
- 失眠的认知行为疗法 (CBT-I) 是主要的基于证据的治疗方法.
- 没有FDA批准的药物用于儿科失眠,但它们是常用的.
- 药物研究的分级是基于疗效,安全性和风险-益处分析.
结论:
- 实践者需要指导如何管理儿科失眠,特别是在考虑药物选择时.
- 本综述通过评估儿童和青少年各种失眠药物的证据和风险,帮助临床决策.
- 关于在儿科失眠中使用药物的知情选择对于患者的安全性和治疗疗效至关重要.
相关概念视频
Management of Insomnia
499
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
499
Sedatives and Hypnotics Drugs: Miscellaneous Agents
477
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
477
Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Sedatives and Hypnotics: Overview
1.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.3K
Insomnia
380
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
380
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174


